Characteristics of Ad-MSCs, BM-MSCs, and XF-iMSCs. Credit: Stem Cell Research & Therapy (2024). DOI: 10.1186/s13287-024-03951-6 A research team led by Associate Professor Hidetoshi Sakurai and Researcher Nana Takenaka-Ninagawa recently demonstrated the superior therapeutic potential of iPS cell-derived mesenchymal stromal cells (iMSCs) compared to primary MSCs as a potential treatment for Ullrich congenital muscular dystrophy. The study is published in Stem...
Tag: <span>muscular dystrophy therapy</span>
Post
A milestone in muscular dystrophy therapy
MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE IN THE HELMHOLTZ ASSOCIATION IMAGE: THE CONFOCAL MICROSCOPE IMAGE SHOWS THE PATIENT’S PRIMARY MUSCLE STEM CELLS, WHICH HAVE CONTINUED TO PROLIFERATE AFTER REPAIR OF THE MUTATION USING “BASE EDITING “. CREDIT: SPULER LAB, ECRC Muscle stem cells enable our muscle to build up and regenerate over a lifetime through...